Global capital pivots to idiosyncratic U.S. assets as macro headwinds intensifyGlobal Report·Jul 24 at 04:13 AMNPT+0.36%NG-1.12%
HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%PUBT·Jul 23 at 11:40 PMLLY+0.26%ELIS0.00%
Major Insider Move Signals Growing Confidence in Parabilis MedicinesTip Ranks·Jul 22 at 09:01 PMPBLS+0.41%
RA Capital Management buys USD 6.84 million of Parabilis Medicines common sharesPUBT·Jul 22 at 03:59 PMPBLS+0.41%
Capital Rotations: A Record Biotech IPO and the Surging European Defense ETFGlobal Report·Jul 21 at 04:13 AMPBLS+0.41%GIS+1.81%
Parabilis Medicines, Inc.'s Quiet Period Set To Expire on July 20th (NASDAQ:PBLS)Market Beat·Jul 13 at 12:20 AMPBLS+0.41%
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga_article·Jul 6 at 06:11 AMWSE+8.00%FRBT-5.41%
Guy Levy Acquires 500,000 Shares of Parabilis Medicines (NASDAQ:PBLS) StockMarket Beat·Jun 30 at 03:07 AMPBLS+0.41%
Major Investor Makes Bold Move in Parabilis Medicines, Inc. StockTip Ranks·Jun 29 at 09:05 PMPBLS+0.41%
Parabilis Medicines files Form 3 initial beneficial ownership statement for Guy LevyPUBT·Jun 29 at 09:39 AMPBLS+0.41%
This little-known biotech just delivered a bigger IPO pop than SpaceX -- and Regeneron is already investedMSN·Jun 27 at 08:09 PMPBLS+0.41%REGN+0.21%
RA Capital Management Discloses Investment at Parabilis Medicines with 23.8% StakeTradingView·Jun 18 at 03:16 PMPBLS+0.41%
Pre-market hot trades in US stocks: Parabilis Medicines up 8.50% in pre-market; Onto Innovation up 7.69% in pre-marketPrice Alert·Jun 15 at 06:57 AMPBLS+0.41%ONTO-8.91%
